1st GIE – May 30-31, 2025
The GIE is a new and original initiative from OESO.
For 36 hours, specialists of the highest level will meet in one room to listen to and discuss 36 presentations on a single topic.
This 36 hour (2 nights) event will offer
an experience which will foster exchanges
and interaction among a group of KOLs
(key opinion leaders), in an informal
country setting, the "Abbaye de Royaumont",
a 13th Century Cistercian Abbey located in
the heart of a forest, only 29 km from Paris.
May 30 and 31, 2025
To our knowledge, this will be
a first-of-its-kind event.
Here below is the preliminary program.
We are looking forward to welcoming you to this event.
For futher information, please contact: gie@oeso.org
- Robert Giuli, MD, FACS, FCCP, Professor of Surgery, Founder & Deputy Executive Director of OESO
robert.giuli@oeso.org - Nikki Johnston, Professor of Otolaryngology, Governor of the OESO-SEMPIRE Platform
NJohnston@mcw.edu - C. Prakash Gyawali, MD, FRCP, Professor of Medicine, Washington University in St. Louis cprakash@wustl.edu
Preliminary program
Day 1
2:30 pm – Introduction to the novel format
3:00-4:30 pm – Session 1:
Current and novel diagnostics
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- Mucosal impedance measurements in diagnosing and phenotyping reflux
- Non-invasive markers for reflux diagnosis (salivary biomarkers)
- Catheter-based vs. wireless reflux monitoring
- Role of endoscopy in reflux diagnosis
- How to diagnose EGJ disruption and hiatus hernia (Hill vs AFS grade)
- Innovation: Development and assessment of a daily reflux symptom diary as a fit-for-purpose clinical outcomes assessment tool to assess LPR symptom severity and its treatment response
- Discussion (30 minutes)
5:00-6:30 pm – Session 2:
Leveraging new acid suppressants in reflux management
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- P-CABs: a new avenue in acid suppression
- Optimizing PPI and H2RA use in reflux disease
- When to consider PCABs in reflux management
- Safety profile and side effects of acid suppressants
- On demand vs. daily acid suppressants: when and which agents
- Innovation: Esophageal clearance mechanisms following reflux episodes
- Discussion (30 minutes)
Day 2
9:00-10:30 am – Session 3:
Adjunctive medical management: Mucosal protectants, Reflux reducers, Neuromodulators
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- Behavioral and lifestyle approaches
- Reflux reducing agents (baclofen, bethanechol, others)
- Mucosal protective compounds for treatment of GERD
- Status of pepsin inhibitors for PPI refractory GERD and LPR
- When are neuromodulators needed in symptomatic reflux disease
- Innovation: What are the roles of sodium alginates and amprenavir against pepsin-mediated esophageal and laryngeal damage?
- Discussion (30 minutes)
11:00-12:30 pm – Session 4:
Advances in invasive reflux management
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- TIF and C-TIF
- Magnetic sphincter augmentation
- Reflux stop
- Bariatric approaches to managing reflux disease
- Complications of invasive anti-reflux therapy
- Innovation: Obesity treatment and reflux
- Discussion (30 minutes)
2:00-3:30 pm – Session 5:
Role of reflux in extra-esophageal syndromes
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- How is pharyngeal reflux diagnosed?
- Laryngo-pharyngeal symptoms and Laryngopharyngeal reflux disease
- Reflux and voice disorders
- Reflux and pulmonary disease
- Reflux and lung transplant outcomes
- Innovation: Reflux vs oropharyngeal dysphagia in pediatric aerodigestive disease
- Discussion (30 minutes)
4:00-5:30 pm – Session 6:
Modern diagnosis of esophageal and laryngeal reflux syndromes
Chairs:
- Chat session panel (30 minutes)
- Questions (5 minutes each)
- Modern diagnosis of GERD: Lyon Consensus 2.0
- Modern diagnosis of LPRD
- Behavioral syndromes in the evaluation of GERD (belching disorders, rumination)
- Esophageal Motility Disorders related to GERD
- Provocative maneuvers and scoring systems predictive of GERD
- Innovation: Proximal esophageal metrics and contractile reserve in LPR
- Discussion (30 minutes)
5:45-6:30 pm: Wrap-up Session